These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6474387)

  • 1. Comparison of cumulative and non-cumulative techniques to measure dose-response curves for beta agonists in patients with asthma.
    Britton J; Tattersfield A
    Thorax; 1984 Aug; 39(8):597-9. PubMed ID: 6474387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-response curves to inhaled beta-adrenoceptor agonists in normal and asthmatic subjects.
    Barnes PJ; Pride NB
    Br J Clin Pharmacol; 1983 Jun; 15(6):677-82. PubMed ID: 6135437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bronchial asthma treated with long-acting beta 2 agonist. Comparison between formoterol (12 mu/g) inhaled twice daily and salbutamol (200 mu/g) inhaled 4 times daily].
    Sprogøe-Jakobsen U; Viktrup L; Davidsen O; Viskum K
    Ugeskr Laeger; 1992 Nov; 154(47):3325-8. PubMed ID: 1361083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of sequential quadrupling dose regimens to study efficacy of inhaled corticosteroids in asthma.
    Phillips K; Oborne J; Harrison TW; Tattersfield AE
    Thorax; 2004 Jan; 59(1):21-5. PubMed ID: 14694241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-response effects of two sizes of monodisperse isoproterenol in mild asthma.
    Patel P; Mukai D; Wilson AF
    Am Rev Respir Dis; 1990 Feb; 141(2):357-60. PubMed ID: 2301853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of prior treatment with salmeterol and formoterol on airway and systemic beta 2 responses to fenoterol.
    Grove A; Lipworth BJ
    Thorax; 1996 Jun; 51(6):585-9. PubMed ID: 8693438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised placebo controlled trial of beta agonist dose reduction in asthma.
    Harrison TW; Oborne J; Wilding PJ; Tattersfield AE
    Thorax; 1999 Feb; 54(2):98-102. PubMed ID: 10325911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regular inhaled beta agonist in asthma: effects on exacerbations and lung function.
    Taylor DR; Sears MR; Herbison GP; Flannery EM; Print CG; Lake DC; Yates DM; Lucas MK; Li Q
    Thorax; 1993 Feb; 48(2):134-8. PubMed ID: 8493626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study with cumulative doses of formoterol and salbutamol in children with asthma.
    Foucard T; Lönnerholm G
    Eur Respir J; 1991 Nov; 4(10):1174-7. PubMed ID: 1687130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative dose-response study of three anticholinergic agents and fenoterol using a metered dose inhaler in patients with chronic obstructive pulmonary disease.
    Ikeda A; Nishimura K; Koyama H; Izumi T
    Thorax; 1995 Jan; 50(1):62-6. PubMed ID: 7886652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-dose comparison of salbutamol and Duovent-Berodual in asthma.
    Crane J
    Respiration; 1986; 50 Suppl 2():285-9. PubMed ID: 2951823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between delta-forced vital capacity (percent fall in forced vital capacity at the PC20 dose of methacholine) and the maximal airway response in patients who have mild asthma.
    Yu J; Yoo Y; Kim DK; Koh YY
    Allergy Asthma Proc; 2005; 26(5):366-72. PubMed ID: 16450571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The protective effect of a beta 2 agonist against excessive airway narrowing in response to bronchoconstrictor stimuli in asthma and chronic obstructive lung disease.
    Bel EH; Zwinderman AH; Timmers MC; Dijkman JH; Sterk PJ
    Thorax; 1991 Jan; 46(1):9-14. PubMed ID: 1871705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-response comparison of ipratropium bromide from a metered-dose inhaler and by jet nebulisation.
    Gomm SA; Keaney NP; Hunt LP; Allen SC; Stretton TB
    Thorax; 1983 Apr; 38(4):297-301. PubMed ID: 6223402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of response to inhaled bronchodilators in asthmatics.
    Paré PD; Lawson LM; Brooks LA
    Am Rev Respir Dis; 1983 Jun; 127(6):680-5. PubMed ID: 6222679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled salmeterol and salbutamol in asthmatic patients. An evaluation of asthma symptoms and the possible development of tachyphylaxis.
    Ullman A; Hedner J; Svedmyr N
    Am Rev Respir Dis; 1990 Sep; 142(3):571-5. PubMed ID: 1975162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the relative airways and systemic potencies of inhaled fenoterol and salbutamol in asthmatic patients.
    Lipworth BJ; Newnham DM; Clark RA; Dhillon DP; Winter JH; McDevitt DG
    Thorax; 1995 Jan; 50(1):54-61. PubMed ID: 7886650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group.
    Maesen FP; Smeets JJ; Sledsens TJ; Wald FD; Cornelissen PJ
    Eur Respir J; 1995 Sep; 8(9):1506-13. PubMed ID: 8575576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose response of patients with asthma to inhaled isoproterenol.
    Williams MH; Kane C
    Am Rev Respir Dis; 1975 Mar; 111(3):321-4. PubMed ID: 1119742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The response of asthmatic subjects to isoproterenol inhaled at differing lung volumes.
    Riley DJ; Weitz BW; Edelman NH
    Am Rev Respir Dis; 1976 Sep; 114(3):509-15. PubMed ID: 970732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.